Torsemide Patent Expiration

Torsemide was first introduced by Pharmobedient Consulting Llc in its drug Demadex on Aug 23, 1993. Another drug containing Torsemide is Soaanz. 12 different companies have introduced drugs containing Torsemide.


Torsemide Patents

Given below is the list of patents protecting Torsemide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Soaanz US10154963 Controlled-release formulations comprising Torsemide Oct 06, 2033 Sarfe Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Torsemide's patents.

Given below is the list recent legal activities going on the following patents of Torsemide.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 4th Yr, Small Entity 17 Aug, 2022 US10154963
Surcharge for late Payment, Small Entity 17 Aug, 2022 US10154963
Maintenance Fee Reminder Mailed 08 Aug, 2022 US10154963
Change in Power of Attorney (May Include Associate POA) 17 Sep, 2021 US10154963
Correspondence Address Change 15 Sep, 2021 US10154963
Patent Issue Date Used in PTA Calculation 18 Dec, 2018 US10154963
Recordation of Patent Grant Mailed 18 Dec, 2018 US10154963
Email Notification 29 Nov, 2018 US10154963
Issue Notification Mailed 28 Nov, 2018 US10154963
Dispatch to FDC 14 Nov, 2018 US10154963


Torsemide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Torsemide Generic API Manufacturers

Several generic applications have been filed for Torsemide. The first generic version for Torsemide was by Teva Pharmaceuticals Usa Inc and was approved on May 14, 2002. And the latest generic version is by Strides Pharma Global Pte Ltd and was approved on Mar 22, 2011.

Given below is the list of companies who have filed for Torsemide generic, along with the locations of their manufacturing plants worldwide.